Zydus Wellness launches VieMax, an adult nutrition product targeting gut health, muscle strength, and immunity, exclusively ...

Zydus Wellness has launched VieMax, a new product in Complan’s range aimed at adult nutrition. Available in vanilla and ...

Patients with metastatic castration-sensitive prostate cancer are recommended to be treated with enzalutamide tablets.

Zydus Lifesciences share price trading maginally lower in the opening trade on October 3 despite the company received ...

Zydus Lifesciences on Wednesday said it has received approval from the US health regulator to produce a generic prostate ...

Zydus Lifesciences receives USFDA approval to manufacture Enzalutamide tablets, a generic prostate cancer treatment drug, for ...

Zydus Lifesciences has received tentative approval from the US Food and Drug Administration (USFDA) to manufacture ...

Tarun Arora, CEO, Zydus Wellness, said, “VieMax is a perfect complement to our existing portfolio at Complan. For more than 50 years, Complan has been synonymous with family nut ...

Ahmedabad: Zydus Lifesciences Limited has received tentative approval from the United States Food and Drug Administration ...

Zydus Lifesciences on Saturday said it has received approval from the US health regulator to produce generic prostate cancer ...

Zydus Lifesciences received an Establishment Inspection Report (EIR) from the USFDA for its Ahmedabad facility. Shares rose ...

"CSIR-CDRI's deep-rooted expertise in biomedical research, coupled with Zydus' innovative approach to drug discovery and ...